Several other HHS policies and regulations apply to grants under this part. These include, but are not necessarily limited to: 37 CFR part 401--Rights to inventions made by nonprofit organizations and small business firms under government grants, contracts, and cooperative agreements42 CFR part 50, subpart A--Responsibility of PHS awardee and applicant institutions for dealing with and reporting possible misconduct in science42 CFR part 50, subpart D--Public Health Service grant appeals procedure42 CFR part 50, subpart F--Responsibility of applicants for promoting objectively in research for which PHS funding is sought45 CFR part 16--Procedures of the Departmental Grant Appeals Board45 CFR part 46--Protection of human subjects45 CFR part 74--Administration of grants45 CFR part 75--Informal grant appeals procedures45 CFR part 76--Governmentwide debarment and suspension (nonprocurement) and governmentwide requirements for drug-free workplace (grants)45 CFR part 80--Nondiscrimination under programs receiving Federal assistance through the Department of Health and Human Services--effectuation of title VI of the Civil Rights Act of 196445 CFR part 81--Practice and procedure for hearings under part 80 of this title45 CFR part 84--Nondiscrimination on the basis of handicap in programs and activities receiving Federal financial assistance45 CFR part 86--Nondiscrimination on the basis of sex in education programs and activities receiving or benefiting from Federal financial assistance45 CFR part 91--Nondiscrimination on the basis of age in HHS programs or activities receiving Federal financial assistance45 CFR part 92--Uniform administrative requirements for grants and cooperative agreements to State and local governments45 CFR part 93--New restrictions on lobbying59 FR 14508 (March 28, 1994)--NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research.
Note: This policy is subject to changes, and interested persons should contact the Office of Research on Women's Health, NIH, Room 201, Building 1, MSC 0161, BETHESDA, MD 20892-0161 (301-402-1770; not a toll-free number) to obtain references to the current version and any amendments.] 59 FR 34496 (July 5, 1994)--NIH Guidelines for Research Involving Recombinant DNA Molecules.
Note: This policy is subject to changes, and interested persons should contact the Office of Recombinant DNA Activities, NIH, Suite 323, 6000 Executive Boulevard, MSC 7010, Bethesda, MD 20892-7010 (301-496-9838; not a toll-free number) to obtain references to the current version and any amendments.] ``PHS Grants Policy Statement,'' DHHS Publication No. (OASH) 94-50,000 (Rev.) April 1, 1994.
Note: This policy is subject to changes, and interested persons should contact the Grants Policy Branch, OASH, Room 17A45, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857 (301-443-1874; not a toll-free number) to obtain references to the current version and any amendments.] ``Public Health Service Policy on Humane Care and Use of Laboratory Animals,'' Office for Protection from Research Risks, NIH (Revised September 1986).
Note: This policy is subject to changes, and interested persons should contact the Office for Protection from Research Risks, NIH, Suite 3B01, 6100 Executive Boulevard, MSC 7507, Rockville, MD 20852-7507 (301-496-7005; not a toll-free number) to obtain references to the current version and any amendments.] [61 FR 55106 Oct. 24, 1996]